Concepedia

Albrecht Stöffler

AS

Statistics

Publications

8

Citations

3.4K

H-Index

8

Active since

2000

Affiliations

MerLion Pharma (Germany)(Current)

New York University

Albrecht Stöffler is an author at MerLion Pharma (Germany) specializing in medicine, neuropharmacology, and alzheimer disease.

Publications per year

2000–2013

8

Publications

8

Memantine in Moderate-to-Severe Alzheimer's Disease

‌Barry Reisberg, Rachelle S. Doody, Albrecht Stöffler et al. · New England Journal of Medicine · 2003 · 2K citations · Full text

Medicine, Neuroscience, Pharmacology +16

Efficacy and Safety of Memantine in Patients With Mild to Moderate Vascular Dementia

Jean‐Marc Orgogozo, Anne‐Sophie Rigaud, Albrecht Stöffler et al. · Stroke · 2002 · 538 citations

Medicine, Pharmacology, Pharmacotherapy +17

Neuroprotective and symptomatological action of memantine relevant for alzheimer’s disease — a unified glutamatergic hypothesis on the mechanism of action

Wojciech Danysz, Chris G. Parsons, Hans Jörg Möbius et al. · Neurotoxicity Research · 2000 · 262 citations

Life Sciences, Neuroscience, Pharmacology +17

A 24-Week Open-Label Extension Study of Memantine in Moderate to Severe Alzheimer Disease

‌Barry Reisberg, Rachelle S. Doody, Albrecht Stöffler et al. · Archives of Neurology · 2006 · 181 citations

Medicine, Pharmacology, Pharmacotherapy +16

Resource Utilisation and Cost Analysis of Memantine in Patients with Moderate to Severe Alzheimer??s Disease

Anders Wimo, Bengt Winblad, Albrecht Stöffler et al. · PharmacoEconomics · 2003 · 167 citations

Pharmacy, Pharmacoeconomics, Pharmacotherapy +16

1–5 of 8